Cover Image

One of the active ingredients in Paeoniae Radix Alba functions as JAK1 inhibitor in rheumatoid arthritis

Objective: We aimed to explore and verify the mechanism underlying the action of the active ingredients of Paeoniae Radix Alba (PRA) in the treatment of rheumatoid arthritis (RA).Methods: The protein targets of PRA's six active ingredients and RA were identified. Then, the intersection of the t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lu Xiao (Author), Shudian Lin (Author), Feng Zhan (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy, Chemical Constituents, and Pharmacological Actions of Radix Paeoniae Rubra and Radix Paeoniae Alba
by: Yu-Qing Tan, et al.
Published: (2020)

Radix Paeoniae Alba attenuates Radix Bupleuri-induced hepatotoxicity by modulating gut microbiota to alleviate the inhibition of saikosaponins on glutathione synthetase
by: Congcong Chen, et al.
Published: (2023)

Transcriptomics- and metabolomics-based integration analyses revealed the potential pharmacological effects and functional pattern of in vivo Radix Paeoniae Alba administration
by: Sining Wang, et al.
Published: (2020)

Prediction and Verification of the Major Ingredients and Molecular Targets of Tripterygii Radix Against Rheumatoid Arthritis
by: Yi Ling, et al.
Published: (2021)

Uncovering the mechanism of the effects of Paeoniae Radix Alba on iron-deficiency anaemia through a network pharmacology-based strategy
by: Xian-wen Ye, et al.
Published: (2020)

Studies on the Changes of Pharmacokinetics Behaviors of Phytochemicals and the Influence on Endogenous Metabolites After the Combination of Radix Bupleuri and Radix Paeoniae Alba Based on Multi-Component Pharmacokinetics and Metabolomics
by: Congcong Chen, et al.
Published: (2021)

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Vishal R. Tandon, et al.
Published: (2022)

Metabolism of Paeoniae Radix Rubra and its 14 constituents in mice
by: Jing Zhang, et al.
Published: (2022)

The mechanism of action of paeoniae radix rubra-angelicae sinensis radix drug pair in the treatment of rheumatoid arthritis through PI3K/AKT/NF-κB signaling pathway
by: Jia Li, et al.
Published: (2023)

Identification of metabolites of Radix Paeoniae Alba extract in rat bile, plasma and urine by ultra-performance liquid chromatographyâquadrupole time-of-flight mass spectrometry
by: Zheng-Wei Chen, et al.
Published: (2014)

JAK inhibitors: a promising direction for treating Rheumatoid Arthritis
by: Pelechas Eleftherios
Published: (2017)

Anti-Oxidant and Anti-Inflammatory Substance Generated Newly in Paeoniae Radix Alba Extract Fermented with Plant-Derived <i>Lactobacillus brevis</i> 174A
by: Shrijana Shakya, et al.
Published: (2021)

Screening of Bioactive Fraction of Radix Paeoniae Alba and Enhancing Anti-Allergic Asthma by Stir-Frying Through Regulating PI3K/AKT Signaling Pathway
by: Xia'nan Sang, et al.
Published: (2022)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
by: Cutolo M, et al.
Published: (2013)

Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis
by: Yujun Tang, et al.
Published: (2020)

Chinese herb pair Paeoniae Radix Alba and Atractylodis Macrocephalae Rhizoma suppresses LPS-induced inflammatory response through inhibiting MAPK and NF-κB pathway
by: Yangyang Zhou, et al.
Published: (2019)

JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data
by: Harrington R, et al.
Published: (2020)

Interaction between rheumatoid arthritis and mediterranean diet on the risk of cardiovascular disease for the middle aged and elderly from National Health and Nutrition Examination Survey (NHANES)
by: Yuwei Zhan, et al.
Published: (2023)

Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis
by: Zhang N, et al.
Published: (2021)

Chishao (Paeoniae Radix Rubra) alleviates intra-hepatic cholestasis by modulating NTCP in rats
by: Xiaoqi Sun, et al.
Published: (2024)

Differential effects of <it>Radix Paeoniae Rubra </it>(<it>Chishao</it>) on cytokine and chemokine expression inducible by mycobacteria
by: Li James, et al.
Published: (2011)

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
by: Irma Convertino, et al.
Published: (2023)

Screening of potential antioxidant bioactive Q-markers of paeoniae radix rubra based on an integrated multimodal strategy
by: Hengli Li, et al.
Published: (2024)

Therapeutic efficacy and safety of Paeoniae Radix Rubra formulae in relieving hyperbilirubinemia induced by viral hepatitis: A meta-analysis
by: Yinqiu eHuang, et al.
Published: (2016)

JAK inhibitors in systemic juvenile idiopathic arthritis
by: Tingyan He, et al.
Published: (2023)

Evaluating the Therapeutic Mechanisms of Selected Active Compounds in Cornus Officinalis and Paeonia Lactiflora in Rheumatoid Arthritis via Network Pharmacology Analysis
by: Qinglin Li, et al.
Published: (2021)

Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
by: Martina Biggioggero, et al.
Published: (2019)

Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-κB and mitogen-activated protein kinase pathways
by: Huey-En Tzeng, et al.
Published: (2018)

Elucidation of the Mechanisms and Effective Substances of Paeoniae Radix Rubra Against Toxic Heat and Blood Stasis Syndrome With a Stage-Oriented Strategy
by: Jing-Jing Xu, et al.
Published: (2022)

Combined Cornus Officinalis and Paeonia Lactiflora Pall Therapy Alleviates Rheumatoid Arthritis by Regulating Synovial Apoptosis via AMPK-Mediated Mitochondrial Fission
by: Lichuang Huang, et al.
Published: (2021)

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
by: Van De Laar CJ, et al.
Published: (2020)

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review's Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Paul Langley
Published: (2020)

JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis
by: Yasmin Adel, et al.
Published: (2021)

Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway
by: Charles J. Malemud
Published: (2010)

Paeoniae Radix Rubra can enhance fatty acid β-oxidation and alleviate gut microbiota disorder in α-naphthyl isothiocyanate induced cholestatic model rats
by: Jing-Jing Xu, et al.
Published: (2022)

Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
by: Jia-Ying Wu, et al.
Published: (2022)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
by: Stephanie Hennigan, et al.
Published: (2008)

Ionic Liquid Transdermal Patches of Two Active Ingredients Based on Semi-Ionic Hydrogen Bonding for Rheumatoid Arthritis Treatment
by: Faxing Zhang, et al.
Published: (2024)

Network Pharmacology-Based Prediction of Active Ingredients and Mechanisms of Lamiophlomis rotata (Benth.) Kudo Against Rheumatoid Arthritis
by: Yunbin Jiang, et al.
Published: (2019)

Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis
by: Robert Freeze, et al.
Published: (2023)